Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL5319 Target Snapshot

Epithelial discoidin domain-containing receptor 1 · SINGLE PROTEIN · Homo sapiens

2,218Compounds
402Assays
28Approved Drugs
2,110.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt Q08345. Use UniProt Q08345 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt Q08345 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Epithelial discoidin domain-containing receptor 1 as ChEMBL target CHEMBL5319, mapped to UniProt Q08345. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Epithelial discoidin domain-containing receptor 1
SINGLE PROTEIN · Homo sapiens
As of 2026-09-13
ChEMBL target ID
CHEMBL5319
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
Q08345
Epithelial discoidin domain-containing receptor 1
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Epithelial discoidin domain-containing receptor 1 is the right protein anchor across sources, using UniProt Q08345 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelEpithelial discoidin domain-containing receptor 1
UniProt AccessionQ08345
Component TypeProtein
Sequence Length913 aa

Epithelial discoidin domain-containing receptor 1

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Epithelial discoidin domain-containing receptor 1, mapped to UniProt Q08345. Sequence length is 913 aa.

Mapped IDQ08345
Review nameEpithelial discoidin domain-containing receptor 1
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

28
Approved
13
Phase III
28
Phase II
12
Phase I
Assay Mix

Activity Type Distribution

IC501,708.0
KI1.0
EC504.0
KD397.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL1230609 9.7 Kd 0.2 Clinical
CHEMBL3907057 9.4 Kd 0.4 Preclinical
CHEMBL5416410 9.3 IC50 0.5 Approved
CHEMBL2336015 9.22 Kd 0.6 Preclinical
CHEMBL5416410 9.16 Kd 0.69 Approved
CHEMBL574738 9.16 Kd 0.69 Preclinical
CHEMBL4539920 9.15 IC50 0.7078 Preclinical
CHEMBL941 9.15 Kd 0.7 Approved
CHEMBL3907057 9.05 IC50 0.9 Preclinical
CHEMBL255863 8.96 Kd 1.1 Approved
Distribution

pChEMBL Value Distribution

57
5.0
149
5.5
197
6.0
316
6.5
552
7.0
400
7.5
84
8.0
22
8.5
14
9.0
2
9.5
pChEMBL
Approved Drugs

Approved Drugs

TOVORAFENIB
CHEMBL3348923
Approved 2024
QUIZARTINIB
CHEMBL576982
Approved 2023
TIVOZANIB
CHEMBL1289494
Approved 2017
LENVATINIB
CHEMBL1289601
Approved 2015
NINTEDANIB
CHEMBL502835
Approved 2014
REGORAFENIB
CHEMBL1946170
Approved 2012
AXITINIB
CHEMBL1289926
Approved 2012
PONATINIB
CHEMBL1171837
Approved 2012
CABOZANTINIB
CHEMBL2105717
Approved 2012
BOSUTINIB
CHEMBL288441
Approved 2012
CRIZOTINIB
CHEMBL601719
Approved 2011
VANDETANIB
CHEMBL24828
Approved 2011
PAZOPANIB
CHEMBL477772
Approved 2009
NILOTINIB
CHEMBL255863
Approved 2007
DASATINIB ANHYDROUS
CHEMBL1421
Approved 2006
DASATINIB
CHEMBL5416410
Approved 2006
SORAFENIB
CHEMBL1336
Approved 2005
ERLOTINIB
CHEMBL553
Approved 2004
IMATINIB
CHEMBL941
Approved 2001
Assay Landscape

Assay Landscape

402
Total Assays
1,709
Tested Compounds
1
Assay Types
Binding — 402 assays, 1,709 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 266 1,194 7.1
assay format 79 96 7.2
cell-based format 52 367 6.8
subcellular format 5 52 6.6

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine